<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:atom="http://www.w3.org/2005/Atom" version="2.0">
  <channel>
    <title>Merz Aesthetics</title>
    <link>https://www.biospace.com/employer/530417/merz-aesthetics-formerly-known-as-bioform-medical-inc</link>
    <description>Merz Aesthetics</description>
    <language>en-US</language>
    <lastBuildDate>Mon, 16 Mar 2020 11:06:10 GMT</lastBuildDate>
    <atom:link href="https://www.biospace.com/employer/530417/merz-aesthetics-formerly-known-as-bioform-medical-inc.rss" type="application/rss+xml" rel="self" />
    <item>
      <title>Merz Aesthetics Appoints Samantha Kerr, Ph.D., as Chief Scientific Officer</title>
      <link>https://www.biospace.com/merz-aesthetics-appoints-samantha-kerr-ph-d-as-chief-scientific-officer</link>
      <description>Merz Aesthetics, today announced the appointment of Samantha Kerr, Ph.D., as Chief Scientific Officer, effective March 16, 2020.</description>
      <pubDate>Mon, 16 Mar 2020 11:06:10 GMT</pubDate>
      <guid>https://www.biospace.com/merz-aesthetics-appoints-samantha-kerr-ph-d-as-chief-scientific-officer</guid>
    </item>
    <item>
      <title>Merz Aesthetics® Taps Gwyneth Paltrow as the Global Face of Xeomin® (incobotulinumtoxinA)</title>
      <link>https://www.biospace.com/merz-aesthetics-taps-gwyneth-paltrow-as-the-global-face-of-xeomin-incobotulinumtoxina</link>
      <description>Merz Aesthetics ® Taps Gwyneth Paltrow as the Global Face of Xeomin ® (incobotulinumtoxinA) This campaign is the first-ever medical aesthetics partnership for goop ® Founder, Gwyneth Paltrow RALEIGH, N.C.--( BUSINESS WIRE )-- Merz Aesthetics, the world’s largest dedicated medical aesthetics business, announced today a partnership with Oscar and Emmy-award-winning actor, author and entrepreneur, Gwyneth Paltrow, for the launch of the company’s firs</description>
      <pubDate>Thu, 17 Sep 2020 11:06:09 GMT</pubDate>
      <guid>https://www.biospace.com/merz-aesthetics-taps-gwyneth-paltrow-as-the-global-face-of-xeomin-incobotulinumtoxina</guid>
    </item>
    <item>
      <title>BioForm Medical, Inc. Release: Radiesse(TM) Injectable Filler Provides 12-Month Improvement Of Vocal Fold Insufficiency In Multicenter Clinical Voice Study</title>
      <link>https://www.biospace.com/bioform-medical-inc-release-radiesse-tm-injectable-filler-provides-12-month-improvement-of-vocal-fold-insufficiency-in-multicenter-clinical-voice</link>
      <description />
      <pubDate>Thu, 25 May 2006 20:10:32 GMT</pubDate>
      <guid>https://www.biospace.com/bioform-medical-inc-release-radiesse-tm-injectable-filler-provides-12-month-improvement-of-vocal-fold-insufficiency-in-multicenter-clinical-voice</guid>
    </item>
    <item>
      <title>BioForm Medical, Inc. Release: FDA Advisory Panel Meeting To Evaluate Radiesse(R), A Next-Generation, Long-Lasting Product For Soft Tissue Augmentation In Two Facial Aesthetic Applications</title>
      <link>https://www.biospace.com/bioform-medical-inc-release-fda-advisory-panel-meeting-to-evaluate-radiesse-r-a-next-generation-long-lasting-product-for-soft-tissue-augmentatio</link>
      <description />
      <pubDate>Wed, 23 Aug 2006 18:04:09 GMT</pubDate>
      <guid>https://www.biospace.com/bioform-medical-inc-release-fda-advisory-panel-meeting-to-evaluate-radiesse-r-a-next-generation-long-lasting-product-for-soft-tissue-augmentatio</guid>
    </item>
    <item>
      <title>FDA Advisory Panel Recommends Approval Of BioForm Medical, Inc.'s RADIESSE(R) For Two Facial Aesthetic Applications</title>
      <link>https://www.biospace.com/fda-advisory-panel-recommends-approval-of-bioform-medical-inc-s-radiesse-r-for-two-facial-aesthetic-applications</link>
      <description />
      <pubDate>Fri, 25 Aug 2006 17:21:55 GMT</pubDate>
      <guid>https://www.biospace.com/fda-advisory-panel-recommends-approval-of-bioform-medical-inc-s-radiesse-r-for-two-facial-aesthetic-applications</guid>
    </item>
    <item>
      <title>CryoLife, Inc. Announces Agreement With BioForm Medical, Inc. To Develop And Market BioGlue(R) For Use In Cosmetic And Plastic Surgery</title>
      <link>https://www.biospace.com/cryolife-inc-announces-agreement-with-bioform-medical-inc-to-develop-and-market-bioglue-r-for-use-in-cosmetic-and-plastic-surgery</link>
      <description />
      <pubDate>Mon, 30 Oct 2006 21:37:35 GMT</pubDate>
      <guid>https://www.biospace.com/cryolife-inc-announces-agreement-with-bioform-medical-inc-to-develop-and-market-bioglue-r-for-use-in-cosmetic-and-plastic-surgery</guid>
    </item>
    <item>
      <title>FDA Approves BioForm Medical, Inc.'s Radiesse(R) Facial Filler For Two New Aesthetic Indications</title>
      <link>https://www.biospace.com/fda-approves-bioform-medical-inc-s-radiesse-r-facial-filler-for-two-new-aesthetic-indications</link>
      <description />
      <pubDate>Wed, 27 Dec 2006 23:01:17 GMT</pubDate>
      <guid>https://www.biospace.com/fda-approves-bioform-medical-inc-s-radiesse-r-facial-filler-for-two-new-aesthetic-indications</guid>
    </item>
    <item>
      <title>BioForm Medical, Inc. Enrolls First Patient in Clinical Trial of CryoLife, Inc.'s BioGlue(R) Surgical Adhesive for Use in Cosmetic and Plastic Surgery</title>
      <link>https://www.biospace.com/bioform-medical-inc-enrolls-first-patient-in-clinical-trial-of-cryolife-inc-s-bioglue-r-surgical-adhesive-for-use-in-cosmetic-and-plastic-surgery</link>
      <description />
      <pubDate>Tue, 26 Jun 2007 20:57:30 GMT</pubDate>
      <guid>https://www.biospace.com/bioform-medical-inc-enrolls-first-patient-in-clinical-trial-of-cryolife-inc-s-bioglue-r-surgical-adhesive-for-use-in-cosmetic-and-plastic-surgery</guid>
    </item>
    <item>
      <title>BioForm Medical, Inc. Files for $115 Million IPO</title>
      <link>https://www.biospace.com/bioform-medical-inc-files-for-115-million-ipo</link>
      <description />
      <pubDate>Tue, 21 Aug 2007 10:18:45 GMT</pubDate>
      <guid>https://www.biospace.com/bioform-medical-inc-files-for-115-million-ipo</guid>
    </item>
    <item>
      <title>ARTES Medical Inc. to Receive $5.5 Million from BioForm Medical, Inc. Under Royalty Agreement</title>
      <link>https://www.biospace.com/artes-medical-inc-to-receive-5-5-million-from-bioform-medical-inc-under-royalty-agreement</link>
      <description />
      <pubDate>Tue, 25 Sep 2007 15:38:37 GMT</pubDate>
      <guid>https://www.biospace.com/artes-medical-inc-to-receive-5-5-million-from-bioform-medical-inc-under-royalty-agreement</guid>
    </item>
  </channel>
</rss>
